Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs-Reference-Cited by-同舟云学术

Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs

Published:2020-03 Issue:2 Volume:34 Page:882-889
ISSN:0891-6640
Container-title:Journal of Veterinary Internal Medicine
language:en
Short-container-title:J Vet Intern Med

Author:

Cawley Jacob R.¹^ORCID,Wright Zachary M.²,Meleo Karri³,Post Gerald S.⁴,Clifford Craig A.⁵,Vickery Kathryn R.⁵,Vail David M.⁶,Bergman Philip J.⁷,Thamm Douglas H.¹⁸⁹^ORCID

Affiliation:

1. Department of Clinical SciencesFlint Animal Cancer Center, Colorado State University Fort Collins Colorado

2. VCA Animal Diagnostic Clinic Dallas Texas

3. BluePearl Pet Hospital Seattle Washington

4. The Veterinary Cancer Center Norwalk Connecticut

5. Hope Veterinary Specialists Malvern Pennsylvania

6. School of Veterinary Medicine, University of Wisconsin‐Madison Madison Wisconsin

7. VCA Katonah Bedford Veterinary Center Bedford Hills New York

8. Cell and Molecular Biology Graduate ProgramColorado State University Fort Collins Colorado

9. Developmental Therapeutics Program, Comprehensive Cancer CenterUniversity of Colorado Aurora Colorado

Funder

VetDC, Inc

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvim.15723

Reference23 articles.

1. A Combination Chemotherapy Protocol (VELCAP-L) for Dogs with Lymphoma

2. Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin's Lymphoma

3. GS-9219—A Novel Acyclic Nucleotide Analogue with Potent Antineoplastic Activity in Dogs with Spontaneous Non–Hodgkin's Lymphoma

4. Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses

5. Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG‐1961);Panosyan EH;Anticancer Res,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma;Journal of Veterinary Internal Medicine;2024-07

2. Novel Treatments for Lymphoma;Veterinary Clinics of North America: Small Animal Practice;2024-05

3. Evaluation of clinical response and prognostic factors in canine multicentric lymphoma treated with first rescue therapy;Veterinary and Comparative Oncology;2024-04-22

4. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23

5. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23